PMID- 35767091 OWN - NLM STAT- MEDLINE DCOM- 20221005 LR - 20221118 IS - 1432-2323 (Electronic) IS - 0364-2313 (Linking) VI - 46 IP - 11 DP - 2022 Nov TI - Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis. PG - 2666-2675 LID - 10.1007/s00268-022-06633-7 [doi] AB - BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1)-associated primary hyperparathyroidism (pHPT) is classically associated with an asymmetric and asynchronous parathyroid involvement. Subtotal parathyroidectomy (STP), which is currently the recommended surgical treatment, carries a high risk of permanent hypoparathyroidism. The results of less than subtotal parathyroidectomy (LSTP) are conflicting, and its place in this setting is still a matter of debate. The aim of this study was to identify the place of LSTP in the surgical management of patients with MEN-associated pHPT. METHODS: A systematic literature review was conducted in accordance with PRISMA and MOOSE guidelines, for studies comparing STP and LSTP for MEN1-associated pHPT. The results of the two techniques, regarding permanent hypoparathyroidism, persistent hyperparathyroidism and recurrent hyperparathyroidism were computed using pairwise random-effect meta-analysis. RESULTS: Twenty-five studies comparing STP and LSTP qualified for inclusion in the quantitative synthesis. In total, 947 patients with MEN1-associated pHPT were allocated to STP (n = 569) or LSTP (n = 378). LSTP reduces the risk of permanent hypoparathyroidism [odds ratio (OR) 0.29, confidence interval (CI) 95% 0.17-0.49)], but exposes to higher rates of persistent hyperparathyroidism [OR 4.60, 95% CI 2.66-7.97]. Rates of recurrent hyperparathyroidism were not significantly different between the two groups [OR 1.26, CI 95% 0.83-1.91]. CONCLUSIONS: LSTP should not be abandoned and should be considered as a suitable surgical option for selected patients with MEN1-associated pHPT. The increased risk of persistent hyperparathyroidism could improve with the emergence of more efficient preoperative localization imaging techniques and a more adequate patients selection. CI - (c) 2022. The Author(s) under exclusive licence to Societe Internationale de Chirurgie. FAU - Bouriez, Damien AU - Bouriez D AD - Digestive and Endocrine Surgery Department, Magellan Center, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France. FAU - Gronnier, Caroline AU - Gronnier C AD - Digestive and Endocrine Surgery Department, Magellan Center, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France. FAU - Haissaguerre, Magalie AU - Haissaguerre M AD - Endocrinology Department, INSERM Unit 1215, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France. FAU - Tabarin, Antoine AU - Tabarin A AD - Endocrinology Department, INSERM Unit 1215, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France. FAU - Najah, Haythem AU - Najah H AUID- ORCID: 0000-0002-9053-6313 AD - Digestive and Endocrine Surgery Department, Magellan Center, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France. haythem.najah@gmail.com. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review PT - Systematic Review DEP - 20220629 PL - United States TA - World J Surg JT - World journal of surgery JID - 7704052 SB - IM CIN - World J Surg. 2022 Nov;46(11):2676-2677. PMID: 36042033 MH - Humans MH - *Hyperparathyroidism, Primary/complications/surgery MH - *Hypoparathyroidism/etiology MH - *Multiple Endocrine Neoplasia Type 1/complications/surgery MH - Parathyroid Glands MH - Parathyroidectomy/adverse effects EDAT- 2022/06/30 06:00 MHDA- 2022/10/06 06:00 CRDT- 2022/06/29 11:16 PHST- 2022/06/06 00:00 [accepted] PHST- 2022/06/30 06:00 [pubmed] PHST- 2022/10/06 06:00 [medline] PHST- 2022/06/29 11:16 [entrez] AID - 10.1007/s00268-022-06633-7 [pii] AID - 10.1007/s00268-022-06633-7 [doi] PST - ppublish SO - World J Surg. 2022 Nov;46(11):2666-2675. doi: 10.1007/s00268-022-06633-7. Epub 2022 Jun 29.